CVS Health Corp (CVS) Holdings Increased by Goelzer Investment Management Inc.
Goelzer Investment Management Inc. raised its holdings in shares of CVS Health Corp (NYSE:CVS) by 12.0% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 88,918 shares of the pharmacy operator’s stock after purchasing an additional 9,499 shares during the period. Goelzer Investment Management Inc.’s holdings in CVS Health were worth $7,000,000 at the end of the most recent quarter.
A number of other institutional investors and hedge funds have also modified their holdings of CVS. BlackRock Inc. boosted its stake in shares of CVS Health by 5.9% in the 2nd quarter. BlackRock Inc. now owns 74,135,102 shares of the pharmacy operator’s stock worth $4,770,597,000 after buying an additional 4,121,620 shares during the last quarter. Charles Schwab Investment Advisory Inc. purchased a new position in shares of CVS Health in the 2nd quarter worth $190,701,000. Boston Partners boosted its stake in shares of CVS Health by 41.9% in the 2nd quarter. Boston Partners now owns 9,908,888 shares of the pharmacy operator’s stock worth $637,637,000 after buying an additional 2,924,875 shares during the last quarter. Morgan Stanley boosted its stake in shares of CVS Health by 28.4% in the 2nd quarter. Morgan Stanley now owns 8,358,263 shares of the pharmacy operator’s stock worth $537,854,000 after buying an additional 1,848,678 shares during the last quarter. Finally, Caisse DE Depot ET Placement DU Quebec boosted its stake in shares of CVS Health by 52.1% in the 2nd quarter. Caisse DE Depot ET Placement DU Quebec now owns 5,171,271 shares of the pharmacy operator’s stock worth $332,771,000 after buying an additional 1,771,170 shares during the last quarter. Institutional investors and hedge funds own 84.50% of the company’s stock.
NYSE:CVS opened at $78.91 on Thursday. The company has a current ratio of 2.44, a quick ratio of 1.94 and a debt-to-equity ratio of 1.66. The stock has a market cap of $80.39 billion, a price-to-earnings ratio of 13.37, a price-to-earnings-growth ratio of 1.13 and a beta of 0.98. CVS Health Corp has a 52 week low of $60.14 and a 52 week high of $83.88.
Several equities analysts recently weighed in on the company. Cantor Fitzgerald assumed coverage on CVS Health in a research report on Sunday. They set an “overweight” rating and a $77.84 target price on the stock. Goldman Sachs Group reiterated a “neutral” rating and set a $87.00 target price on shares of CVS Health in a research report on Thursday, November 29th. Evercore ISI assumed coverage on CVS Health in a research report on Wednesday, November 28th. They set an “outperform” rating and a $89.00 target price on the stock. Loop Capital set a $80.00 target price on CVS Health and gave the company a “hold” rating in a research report on Wednesday, November 28th. Finally, Wells Fargo & Co lifted their target price on CVS Health from $98.00 to $104.00 and gave the company an “outperform” rating in a research report on Tuesday, November 27th. One analyst has rated the stock with a sell rating, four have assigned a hold rating, fourteen have given a buy rating and two have issued a strong buy rating to the stock. The company presently has an average rating of “Buy” and a consensus price target of $90.69.
In other CVS Health news, EVP Troyen A. Brennan sold 14,229 shares of the firm’s stock in a transaction dated Wednesday, November 14th. The stock was sold at an average price of $82.00, for a total transaction of $1,166,778.00. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, CFO David M. Denton sold 25,159 shares of the firm’s stock in a transaction dated Thursday, November 29th. The shares were sold at an average price of $80.13, for a total value of $2,015,990.67. Following the sale, the chief financial officer now directly owns 403 shares in the company, valued at $32,292.39. The disclosure for this sale can be found here. Over the last three months, insiders have sold 74,233 shares of company stock worth $5,932,565. Insiders own 0.53% of the company’s stock.
TRADEMARK VIOLATION WARNING: “CVS Health Corp (CVS) Holdings Increased by Goelzer Investment Management Inc.” was reported by Daily Political and is owned by of Daily Political. If you are reading this news story on another publication, it was copied illegally and republished in violation of international copyright law. The original version of this news story can be viewed at https://www.dailypolitical.com/2018/12/06/cvs-health-corp-cvs-holdings-increased-by-goelzer-investment-management-inc.html.
CVS Health Profile
CVS Health Corporation, together with its subsidiaries, provides integrated pharmacy health care services. It operates through Pharmacy Services and Retail/LTC segments. The Pharmacy Services segment offers pharmacy benefit management solutions, such as plan design and administration, formulary management, Medicare Part D services, mail order, specialty pharmacy and infusion services, retail pharmacy network management services, prescription management systems, clinical services, disease management programs, and medical pharmacy management services.
See Also: Intrinsic Value
Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corp (NYSE:CVS).
Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.